Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Ileana L Piña , Chiadi Ndumele , Mitja Lainscak , et al Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Ahmed Bennis, Dr Ileana L Pina, Dr Giulia Ferrannini, Dr Chiadi Ndumele, Prof Rodica Pop-Busui and Prof Mitja Lainscak discuss the epidemiology and pathophysiology of CRM disease. View more
Added: 7 months ago Source:  Radcliffe Cardiology
The long-standing practice of prescribing beta-blockers after a myocardial infarction (MI) has been re-examined in the contemporary era of reperfusion therapy. New findings from the REBOOT-CNIC trial suggest that for patients with a preserved left ventricular ejection fraction (LVEF), this routine therapy may not provide the expected benefits.¹REBOOT-CNIC was an open-label, randomised trial… View more
Author(s): Harriette Van Spall , Dan Atar , Anna Meta Dyrvig Kristensen Added: 8 months ago
ESC Congress 2025 - Long-term beta-blocker therapy after myocardial infarction reduced the primary endpoint of death from any cause or major adverse cardiovascular events.Late-breaker host Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Dan Atar (Oslo University Hospital Ulleval, NO) and Dr Anna Meta Dyrvig Kristensen (Bispebjerg and Frederiksberg Hospital, DK) to discuss the… View more
Job title: Professor
Dr Adam Sung (Dr Shih-Hsien Sung) received his MD and PhD degrees fromNational Yang-Ming University, Taiwan,in 2001 and 2014, respectively. He has been on the faculty of National Yang Ming Chiao Tung University since 2019, where he is currently a professor. He completed internal medicine residency training and cardiology fellowship training at Taipei Veterans General Hospital in 2009, where he is… View more
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 1 year ago
Keep up to date with the top trials from AHA 24!CLEAR-SYNERGYSELECT-CABGSUMMITYELLOW IIIInternational Aortic Stenosis RegistryAMPLATZER IDEVALOR HCMWatch our full AHA 24 coverage in our Late-Breaking and Featured Science Collection. View more
Author(s): Lars H Lund , Marco Metra , Nikolaus Marx , et al Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Intissar Haddiya, Dr Lars Lund, Prof Marco Metra, Prof Nikolaus Marx, Prof Peter Rossing and Prof Giuseppe Rosano discuss guideline directed therapy for CRM disease. View more
Research Area(s) / Expertise: Job title: President of the European Association of Cardiovascular Imaging
Dr Victoria Delgado is a board-certified cardiologist specialising in cardiovascular imaging and currently based in Leiden, the Netherlands. She works at Leiden University Medical Center, where she combines clinical practice with academic research and teaching. Over the past decade, she has become internationally recognised for her contributions to cardiovascular imaging and heart failure… View more
Author(s): Nicolas M Van Mieghem , Azeem Latib Added: 1 month ago
What’s Hot at ACC.26: in this focused preview, Dr Azeem Latib (Montefiore Medical Center, US) and Prof Nicolas Van Mieghem, MD, PhD, pick out the late‑breaking clinical trials at ACC.26 that are most likely to influence practice for operators heading to New Orleans. In a fast, conversational format, they move from pulmonary embolism and left atrial appendage closure to heart failure, STEMI… View more
Research Area(s) / Expertise:

Heart Failure

Cardiomyopathies

Job title: Senior Consultant
Dr Wong is a Senior Consultant in the Department of Cardiology at the National University Heart Centre in Singapore. His specialities include cardiac imaging (echocardiography and nuclear cardiology), cardiomyopathy and heart failure. Dr Raymond Wong is an Editorial Board member ofCardiac Failure Review. View more